Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-22

Clinical Trial Update: Zoledronic Acid in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial of zoledronic acid in rheumatoid arthritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Carmen Gómez-Vaquero | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: TERMINATED